Bronchopulmonary Dysplasia: When the Very Preterm Baby Comes Home

Connie Anderson1, Noah H Hillman1

  • 1Connie Anderson, MD, Assistant Professor, and Noah Hillman, MD, Associate Professor; Division of Neonatology, Department of Pediatrics, Cardinal Glennon Children's Hospital Saint Louis University, St. Louis, Missouri.

Missouri Medicine
|May 2, 2019
PubMed

Insights

Home oxygen therapy is safe for infants with severe bronchopulmonary dysplasia (BPD). This review details outpatient management, monitoring, and weaning, noting long-term pulmonary and cardiovascular risks requiring ongoing care.

Area of Science:

  • Pediatrics
  • Pulmonology
  • Neonatology

Background:

  • Infants with severe bronchopulmonary dysplasia (BPD) often require long-term respiratory support.
  • Home oxygen therapy presents a viable management option for these patients.

Purpose of the Study:

  • To review criteria, monitoring, and weaning protocols for home oxygen therapy in infants with BPD.
  • To highlight long-term pulmonary and cardiovascular sequelae in BPD survivors.

Main Methods:

  • Literature review of studies on home oxygen therapy for BPD.
  • Analysis of outpatient management strategies and follow-up care recommendations.

Main Results:

  • Home oxygen therapy can be safely administered to infants with severe BPD.
  • Most infants are weaned from oxygen within one year.
  • Long-term pulmonary function abnormalities persist into adolescence.

Conclusions:

  • Outpatient management of BPD requires careful consideration of home oxygen therapy protocols.
  • Ongoing monitoring for pulmonary hypertension, systemic hypertension, and nutritional status is crucial for BPD survivors.

Related Concept Videos